Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • No change in audited...

    No change in audited results, evaluating bids: Fortis

    Written by Ruby Khatun Khatun Published On 2018-07-07T15:57:01+05:30  |  Updated On 7 July 2018 3:57 PM IST
    No change in audited results, evaluating bids: Fortis

    New Delhi: Fortis Healthcare said there has been no change in its audited financial results compared to the unaudited numbers reported on June 27, 2018.


    The company on June 27 had reported widening of consolidated net loss to Rs 914.32 crore for the March quarter, 2017-18, hit by continuing business challenges, provisions, and impairments. It had posted a net loss of Rs 37.52 crore in the year-ago period.


    "The audited financial statements have been released on the completion of the additional review of certain internal processes which were being undertaken at the request of the Board of Directors", Fortis said in a filing to BSE.



    As expected, there has been no change in the figures reported in the audited financial statements compared to the unaudited results announced on June 27, it added.

    "With the release of the audited financial statements, we have addressed an important objective that we had set for ourselves, as a reconstituted board comprising independent directors, in the backdrop of recent developments," Fortis Healthcare Board of Directors Chairman Ravi Rajagopal said.


    Our focus in the future will be on strengthening governance and transparency and restoring the health of the business, he added.


    "We are also in the process of evaluating the bids received on July 3, 2018, and will present our recommendation to the shareholders in the coming days," he said.


    Consolidated income from operations stood at Rs 1,086.38 crore for the reported quarter. It was Rs 1,123.43 crore for the same period a year ago, Fortis had said.


    For entire 2017-18, the company posted a net loss of Rs 934.42 crore. It reported a profit of Rs 479.29 crore in 2016-17, it added.


    Consolidated income from operations stood at Rs 4,560.81 crore during 2017-18 as compared to Rs 4,573.71 crore in the preceding year.


    Fortis has received two fresh binding bids on July 3, from Malaysia's IHH Healthcare and Manipal-TPG combine. Two suitors, KKR-backed Radiant Life Care and Munjal-Burman combine, have backed out from the race for the cash-strapped healthcare chain.

    audited financial resultsaudited resultsBidsBinding bidsboard of directorsevaluatingFortisFortis HealthcareIHH HealthcareimpairmentsKKRManipal-TPG combineMarch-quarterMunjal-Burman combinenet lossNo changeprovisionsRadiant Life CareRavi Rajagopal
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok